Corominas, H., Castellví, I., Diaz-Torné, C., Matas, L., de la Rosa, D., Mangues, M. A., . . . Domingo, P. (2021). Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2. Medicine (Baltimore).
Chicago Style CitationCorominas, Hèctor, et al. "Sarilumab (IL-6R Antagonist) in Critically Ill Patients With Cytokine Release Syndrome By SARS-CoV2." Medicine (Baltimore) 2021.
Cita MLACorominas, Hèctor, et al. "Sarilumab (IL-6R Antagonist) in Critically Ill Patients With Cytokine Release Syndrome By SARS-CoV2." Medicine (Baltimore) 2021.
Atenció: Aquestes cites poden no estar 100% correctes.